The resolution asks the FDA to review abortion pill safety again. It also asks the agency to share a full public report on real-world problems and outcomes. It does not change access rules by itself.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. is a House bill in committee. The latest recorded action: Referred to the House Committee on Energy and Commerce.
Latest action on H.Res. 803: Referred to the House Committee on Energy and Commerce.
Who this affects: This bill mainly affects people who use or may use abortion pills, health care providers who prescribe them, and pharmacies that dispense them. It could also matter to the FDA, drug makers, and groups involved in abortion policy. The real impact depends on whether the FDA follows the request and what any review finds.
Why this matters: This matters because abortion pills are widely used, and the resolution could push the FDA to revisit how safe they are in real life. A new review could affect labels, monitoring, or rules for getting the drugs in the future. It also sits inside a larger fight over abortion access, FDA authority, and state abortion laws. The resolution only asks the FDA to act, so the practical effect is uncertain.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
